INHIBITION OF BETA-PROPIOLACTONE-INDUCED MUTAGENESIS AND NEOPLASIA BY SODIUM THIOSULFATE
- 15 August 1987
- journal article
- research article
- Vol. 47 (16) , 4351-4354
Abstract
Studies have been initiated to find compounds that can trap direct-acting carcinogens within the stomach. Sodium thiosulfate (STS) is a potent nucleophile and in initial experiments was found to inhibit mutagenesis resulting from exposure of Salmonella typhimurium strain TA100 to the direct-acting carcinogens .beta.-propiolactone and styrene oxide. In in vitro experiments STS was shown to maintain its nucleophilicity in the acid pH range. It reacted with .beta.-propiolactone as rapidly at pH 2 as at pH 7.4. Thus STS has the prerequisite attributes to inhibit the carcinogenic effects of electrophiles in the stomach. Experiments were performed in which STS was administered by p.o. intubation to female A/J mice 5 min before p.o. administration of .beta.-propiolactone. Under these conditions, inhibition of formation of the forestomach tumors occurred. The data obtained suggest that use of nucleophiles to protect against direct-acting carcinogens is a potential strategy for chemoprevention.This publication has 4 references indexed in Scilit:
- Sodium thiosulfate inhibits cis-diamminedichloroplatinum (II) activityCancer Chemotherapy and Pharmacology, 1984
- 2-ROUTE CHEMOTHERAPY USING HIGH-DOSE IP CISPLATIN AND IV SODIUM THIOSULFATE, ITS ANTIDOTE, FOR PERITONEALLY DISSEMINATED CANCER IN MICE1984
- Revised methods for the Salmonella mutagenicity testMutation Research/Environmental Mutagenesis and Related Subjects, 1983
- INTRAPERITONEAL CIS-DIAMMINEDICHLOROPLATINUM WITH SYSTEMIC THIOSULFATE PROTECTION1983